LSL Pharma Group Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Jul '21 Jul 31, 2021
Cash & Equivalents	0.77	0.55	0.3	0.01	0.01	-
Cash & Short-Term Investments	0.77	0.55	0.3	0.01	0.01	-
Cash Growth	334.46%	85.14%	3600.00%	-	-	-
Accounts Receivable	6.71	5.5	4.95	2.68	1.23	-
Other Receivables	-	-	-	-	-	0.02
Total Trade Receivables	6.71	5.5	4.95	2.68	1.23	0.02
Inventory	17.31	12.35	9.22	4.11	2.96	-
Other Current Assets	1.49	5.7	1.02	0.41	0.21	-
Total Current Assets	26.27	24.1	15.48	7.2	4.4	0.02
Net Property, Plant & Equipment	32.38	32.77	22.94	14.75	13.92	-
Other Intangible Assets	18.67	17.47	13.27	8.93	8.98	-
Goodwill	2.44	0.16	0.16	-	-	-
Other Long-Term Assets	0.24	0.24	1.77	0.02	0.02	-
Total Assets	80.01	74.74	53.61	30.9	27.31	0.02
Accounts Payable	8.96	6.23	5.3	5.98	6.12	0.09
Short-Term Debt	8.28	2.53	2.56	3.77	3.78	0.11
Current Portion of Long-Term Debt	1.47	0.87	1.45	5.22	1.58	-
Current Portion of Leases	1.03	0.69	0.45	0.12	0.14	-
Unearned Revenue	-	-	-	-	0.01	-
Total Current Liabilities	19.73	10.31	9.75	15.07	11.62	0.2
Long-Term Debt	25.82	26.66	12.75	4.73	7.84	-
Long-Term Leases	7.1	7.61	4.66	2.44	2.56	-
Other Long-Term Liabilities	3.19	3.19	1.79	-	-	-
Total Long-Term Liabilities	36.12	37.46	19.2	7.17	10.4	-
Total Liabilities	55.84	47.77	28.72	22.25	22.02	0.2
Common Stock	40.47	40.47	36.39	24.2	15.05	2.93
Additional Paid-in Capital	4.25	4.24	3.42	2.69	-	0.45
Retained Earnings	-20.55	-17.74	-14.92	-18.23	-9.76	-3.56
Shareholders' Equity	24.17	26.97	24.89	8.66	5.29	-0.19
Total Liabilities & Equity	80.01	74.74	53.61	30.9	27.31	17.31
Total Debt	43.69	38.35	21.87	16.27	15.9	0.11
Net Cash (Debt)	-42.93	-37.8	-21.57	-16.26	-15.89	-0.11
Net Cash Per Share	-0.23	-0.32	-0.20	-0.20	-0.24	-0.01
Book Value	24.17	26.97	24.89	8.66	5.29	-0.19
Book Value Per Share	0.13	0.23	0.24	0.11	0.08	-0.01
Tangible Book Value	3.06	9.34	11.46	-0.28	-3.69	-0.19
Tangible Book Value Per Share	0.02	0.08	0.11	-0.00	-0.05	-0.01